rufloxacin has been researched along with carbostyril in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (6.58) | 18.7374 |
1990's | 59 (77.63) | 18.2507 |
2000's | 12 (15.79) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cerretani, D; Moltoni, L; Segre, G; Urso, R | 1 |
Cogo, R; Imbimbo, BP; Mattina, R; Rimoldi, R | 1 |
Imbimbo, BP; Peeters, A; van den Biggelaar-Martea, M; Vree, TB | 1 |
Brancato, R; Cremonesi, F; Ghione, M; Lombardo, N; Manitto, MP; Nucci, P | 1 |
Ardemagni, R; Colzani, V; Lombardi, F; Visconti, M | 1 |
Andrews, JM; Matthews, R; Wise, R; Wolstenholme, M | 1 |
Gollapudi, S; Perumal, V; Thadepalli, H | 1 |
Caglio, G; Cantoni, L; Carmignani, G; Gusmitta, A; Maffezzini, M; Monti Bragadin, C; Samer, L | 1 |
Cohen, GM; Griess, RS; Imbimbo, BP; Kisicki, JC; McCormack, RJ; Ott, CL; Troetel, WM | 1 |
Bonina, L; Carbone, M; Costa, GB; Mastroeni, P | 1 |
Broggini, M; D'Incalci, M; Fabbri, S; Pagella, P | 1 |
Carlucci, G; Fanini, D; Mazzeo, P; Palumbo, G | 1 |
Bonfiglio, G; Cesana, M; Cocuzza, CE; Gulisano, G; Imbimbo, BP; Mattina, R | 1 |
Bach, D; Boerema, JB; Jol, C; Pahlmann, W | 1 |
Bischoff, W; Boerema, JB; Focht, J; Naber, KG | 1 |
Bonfiglio, G; Cesana, M; Cocuzza, CE; Mattina, R | 1 |
Andrews, JM; Imbimbo, BP; Johnson, J; O'Sullivan, N; Wise, R | 1 |
Carlucci, G; Palumbo, G | 1 |
Attardo-Parrinello, G; Broccali, G; Cesana, M; Crema, F; Imbimbo, BP | 1 |
Broccali, G; Cesana, M; Crema, A; Imbimbo, BP | 1 |
Bossù, E; Farina, A; Melchiorre, P; Pagella, P; Quaglia, MG | 1 |
Carlucci, G; Fanini, D; Palumbo, G; Pantaleoni, GC | 1 |
Farina, A | 1 |
Colombrita, D; Foresti, I; Peroni, L; Pinsi, G; Pirali, F; Ravizzola, G; Turano, A | 1 |
Cerretani, D; Cerri, D; Moltoni, L; Segre, G | 1 |
Bellotti, M; Mattina, R; Raimondi, A; Sander, K | 1 |
Aguilar, L; Giménez, MJ; Jiménez de Anta, MT; Marco, F; Marcos, MA; Salvá, P | 1 |
Cesana, M; Jardin, A | 1 |
Bach, D; Cesana, M; Hübner, A; Plétan, Y; van Breukelen, G; van den Berg-Segers, A | 1 |
Allocco, A; Carlone, NA; Cuffini, AM; De Leo, C; Paizis, G; Tullio, V | 1 |
Bisignano, G; Cerniglia, G; Cesana, M; Furneri, PM; Nicoletti, G; Tempera, G | 1 |
Aguilar, L; Fernández-Roblas, R; García-Corbeira, P; López, JC; Soriano, F | 1 |
Cesana, M; Colturani, F; Faleschini, E; Franzini, P; Imbimbo, BP; Lombardi, F; Nicastro, G; Privitera, G; Tagliabue, G; Visconti, M | 1 |
Andrews, J; Greaves, I; Honeybourne, D; Imbimbo, BP; Wise, R | 1 |
Andrews, JM; Wise, R | 1 |
Chuah, SK; Gollapudi, SV; Harvey, T; Thadepalli, H; Thadepalli, HD | 1 |
Cecchetti, V; Fravolini, A; Pagella, PG; Savino, A; Tabarrini, O | 1 |
Bargiggia, S; Bianchi Porro, G; Broccali, G; Dal Bo, L; Imbimbo, BP; Lazzaroni, M; Sangaletti, O | 1 |
Cesana, M; Focht, J; Klietmann, W; Rondel, RK | 1 |
Imbimbo, BP; Mant, TG; Morrison, PJ; Perry, G; Sacks, S; Wise, R; Woodcook, J | 1 |
Postle, G; Qadri, SM; San Pedro, J; Tullo, D; Ueno, Y | 1 |
Oliaro, A | 1 |
Norte, V; Panchal, S; Piddock, LJ | 1 |
Granai, F; Imbimbo, BP; Triger, DR; Wise, R; Woodcock, J | 1 |
Carlucci, G; Mazzeo, P; Palumbo, G | 2 |
Cecchetti, V; Fravolini, A; Pagella, PG; Tabarrini, O; Wise, R | 1 |
Aguilar, L; Balcabao, IP; Costa, J; Dal-ré, R; Martín, M; Prieto, J; Salvá, P | 1 |
Aguilar, L; Caffaratti, J; Dal-Ré, R; Dalet, F; Del Río, G | 1 |
Carlucci, G; Mazzeo, P | 1 |
Gomez-Lus, ML; Herrera, I; Martin, M; Martinez, P; Perez, P; Prieto, J | 1 |
Acar, JF; Bauernfeind, A; Duval, J; Finch, RG; Focht, J; Nicoletti, G; Phillips, I; Pratts, G; Schito, GC; Soriano, F; Wiedeman, B; Wise, R | 1 |
D'Antonio, D; Di Marzio, A; Fioritoni, G; Lacone, A; Lombardo, M; Pizzigallo, E; Romano, F; Staniscia, T; Violante, B | 1 |
Choi, EC; Choi, KH; Hong, JS; Kim, SK; Lee, DK; Yoon, SJ | 1 |
Aguilar, L; Costa, J; Dal-Ré, R; Giménez, MJ; Prieto, J | 1 |
Aguilar, L; Ballesteros, J; Giménez, MJ; Marco, F; Olmos, L; Vázquez, JA; Vila, J | 1 |
Dreassi, E; Furlanetto, S; Gratteri, P; Leardi, R; Pinzauti, S; Santoni, G | 1 |
Cesana, M; Fuhr, U; Kinzig-Schippers, M; Müller, C; Rietbrock, S; Sörgel, F; Staib, AH | 1 |
Braga, PC; Dal Sasso, M; Sala, MT | 1 |
Asuquo, AE; Jin, YF; Piddock, LJ; Ricci, V | 1 |
Chillemi, R; Condorelli, G; De Guidi, G; Giuffrida, S; Sciuto, S; Sortino, S | 1 |
Cesana, M; Moretti, MV; Pauluzzi, S | 1 |
Belgrano, E; Buttazzi, L; Ciampalini, S; Lissiani, A; Plaino, F; Raber, M; Savoca, G | 1 |
Wang, EH; Xiong, WN | 1 |
Coran, S; Furlanetto, S; Orlandini, S; Pinzauti, S; Porta, EL | 1 |
Bauer, TM; Bory, F; Clemente, G; Follo, A; Navasa, M; Planas, R; Rodés, J; Vaquer, P; Vargas, V; Vila, J | 1 |
Belvedere, A; Boscá, F; Catalfo, A; Cuquerella, MC; de Guidi, G; Miranda, MA | 2 |
Belvedere, A; Boscá, F; Cuquerella, MC; de Guidi, G; Miranda, MA | 1 |
Luo, K; Luo, SD; Pan, XG; Shen, XL; Zhang, XZ | 1 |
Boldrini, E; Campa, M; Celandroni, F; Davini, P; Ghelardi, E; Parisio, E; Salvetti, S; Senesi, S; Tavanti, A | 1 |
Belvedere, A; Catalfo, A; De Guidi, G; Renis, M; Scifo, C; Stella, S | 1 |
Bellotti, MG; Bonfiglio, G; Cocuzza, CE; Mattina, R | 1 |
Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
Calandra, ML; Catalfo, A; De Guidi, G; Renis, M; Serrentino, ME | 1 |
2 review(s) available for rufloxacin and carbostyril
Article | Year |
---|---|
Comparison of single preoperative oral rufloxacin versus perioperative ciprofloxacin as prophylactic agents in transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Urethra; Urologic Surgical Procedures | 2000 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
17 trial(s) available for rufloxacin and carbostyril
Article | Year |
---|---|
Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Topics: Adult; Anti-Infective Agents; Fluoroquinolones; Half-Life; Humans; Male; Quinolones | 1992 |
Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Drug Administration Schedule; Fluoroquinolones; Half-Life; Humans; Male; Middle Aged; Quinolones | 1991 |
An open multicentre study on the efficacy and safety of rufloxacin in patients with chronic bacterial prostatitis.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones | 1991 |
Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Caffeine; Fluoroquinolones; Humans; Male; Quinolones; Theophylline | 1991 |
Comparison of rufloxacin and norfloxacin effects on faecal flora.
Topics: Adult; Anti-Infective Agents; Bacteroides fragilis; Colony Count, Microbial; Escherichia coli; Feces; Fluoroquinolones; Humans; Male; Norfloxacin; Quinolones | 1995 |
Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Cystitis; Double-Blind Method; Escherichia coli; Female; Fluoroquinolones; Humans; Middle Aged; Pefloxacin; Proteus mirabilis; Quinolones | 1995 |
Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Escherichia coli Infections; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Pyelonephritis; Quinolones; Treatment Outcome | 1995 |
Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin.
Topics: Administration, Oral; Adult; Aluminum Hydroxide; Antacids; Anti-Infective Agents; Biological Availability; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Female; Fluoroquinolones; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Quinolones | 1993 |
Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Infective Agents; Bacteria; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Sputum | 1993 |
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.
Topics: Adult; Anti-Infective Agents; Bacteriuria; Cross-Over Studies; Escherichia coli Infections; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Serum Bactericidal Test; Staphylococcal Infections | 1996 |
Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations.
Topics: Adult; Anti-Infective Agents; Cystitis; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Quinolones; Recurrence | 1996 |
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteroides; Colony Count, Microbial; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mouth; Neoplasms; Pilot Projects; Quinolones; Staphylococcus; Streptococcus | 1996 |
Suspicion of quinolone active metabolite following discrepancy between predicted and experimental urine bactericidal activities.
Topics: Anti-Infective Agents; Area Under Curve; Escherichia coli; Fluoroquinolones; Humans; Norfloxacin; Predictive Value of Tests; Quinolones; Staphylococcus aureus | 1997 |
Development of in-vivo resistance after quinolone treatment of gonococcal urethritis.
Topics: Adult; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Gonorrhea; Humans; Neisseria gonorrhoeae; Quinolones; Urethritis | 1997 |
Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.
Topics: Adult; Anti-Infective Agents; Cross-Over Studies; Drug Interactions; Fluoroquinolones; Humans; Male; Quinolones; Theophylline | 1998 |
Comparison of single preoperative oral rufloxacin versus perioperative ciprofloxacin as prophylactic agents in transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Urethra; Urologic Surgical Procedures | 2000 |
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.
Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Quinolones; Secondary Prevention; Treatment Outcome | 2002 |
58 other study(ies) available for rufloxacin and carbostyril
Article | Year |
---|---|
Pharmacokinetics of rufloxacin in healthy volunteers.
Topics: Administration, Oral; Analysis of Variance; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Quinolones; Reference Values | 1992 |
Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infections.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Half-Life; Humans; Male; Middle Aged; Models, Biological; Quinolones; Respiratory Tract Infections; Spectrophotometry, Ultraviolet | 1992 |
High-performance liquid chromatography and preliminary pharmacokinetics of rufloxacin and its metabolites, N-desmethylrufloxacin and rufloxacinsulfoxide, in urine of rhesus monkey Macaca mulatta.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Macaca mulatta; Quinolones; Spectrophotometry, Ultraviolet; Sulfoxides; Thiazines | 1992 |
Ocular pharmacokinetics of rufloxacin a new fluoroquinolone antibiotic.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Eye; Fluoroquinolones; Half-Life; Injections, Intravenous; Quinolones; Rabbits; Time Factors; Tissue Distribution; Vitreous Body | 1992 |
High-performance liquid chromatographic determination of rufloxacin and its main active metabolite in biological fluids.
Topics: Anti-Infective Agents; Bile; Chromatography, High Pressure Liquid; Dealkylation; Drug Stability; Fluoroquinolones; Humans; Quinolones; Spectrometry, Fluorescence | 1992 |
The in-vitro activity of two new quinolones: rufloxacin and MF 961.
Topics: Anti-Infective Agents; Bacteria; beta-Lactamases; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1992 |
Effect of rufloxacin on in-vitro proliferation and differentiation of human mononuclear cells.
Topics: Anti-Infective Agents; B-Lymphocytes; Cell Differentiation; Cell Division; Cell Survival; Fluoroquinolones; Humans; Immunoglobulin G; In Vitro Techniques; Mitogens; Monocytes; Phytohemagglutinins; Quinolones; Receptors, Immunologic; Receptors, Interleukin-1; Receptors, Interleukin-2; T-Lymphocytes | 1992 |
[Treatment with rufloxacin of complicated urinary tract infections].
Topics: Adult; Aged; Anti-Infective Agents; Cystitis; Drug Evaluation; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones | 1992 |
Effects of rufloxacin in Salmonella typhimurium infection in mice.
Topics: Animals; Anti-Infective Agents; Disease Susceptibility; Female; Fluoroquinolones; Immunity, Innate; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Quinolones; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1992 |
The inhibition of supercoiling activity of DNA gyrase from Micrococcus luteus caused by rufloxacin (MF 934) and MF 961.
Topics: 4-Quinolones; Anti-Infective Agents; DNA, Superhelical; Fluoroquinolones; Micrococcus; Quinolones; Topoisomerase II Inhibitors | 1991 |
Determination of rufloxacin, a new tricyclic fluoroquinolone in biological fluids using high-performance liquid chromatography with ultraviolet detection.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Fluoroquinolones; Humans; Quinolones; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Ultraviolet Rays | 1991 |
Penetration of rufloxacin into human prostatic tissue and fluid.
Topics: Adult; Aged; Anti-Infective Agents; Body Fluids; Fluoroquinolones; Humans; Male; Middle Aged; Prostate; Quinolones | 1991 |
In vitro activity of a new quinolone, rufloxacin, against nosocomial isolates.
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Fluoroquinolones; Humans; Quinolones | 1991 |
Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Delayed-Action Preparations; Fluoroquinolones; Half-Life; Humans; Male; Quinolones | 1991 |
Analytical procedure for the determination of rufloxacin, a new pyridobenzothiazine, in human serum and urine by high-performance liquid chromatography.
Topics: 4-Quinolones; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Quinolones | 1991 |
Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Half-Life; Humans; Individuality; Male; Microbial Sensitivity Tests; Models, Biological; Quinolones; Spectrophotometry, Ultraviolet | 1991 |
The analytical profile of rufloxacin, a new fluoroquinolone, by reversed-phase high-performance liquid chromatography.
Topics: 4-Quinolones; Anti-Infective Agents; Capsules; Chromatography, High Pressure Liquid; Fluoroquinolones; Indicators and Reagents; Quinolones; Solutions; Spectrophotometry, Ultraviolet | 1990 |
Rufloxacin, a new fluoroquinolone in biological fluids by high-performance liquid chromatography.
Topics: 4-Quinolones; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Quinolones | 1990 |
Fluorimetric assay of rufloxacin in serum and in pharmaceutical formulations.
Topics: 4-Quinolones; Anti-Infective Agents; Capsules; Fluoroquinolones; Humans; Indicators and Reagents; Quinolones; Reference Standards; Spectrometry, Fluorescence | 1989 |
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Female; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Skin Diseases, Infectious | 1989 |
A new tricyclic fluoroquinolone, rufloxacin (MF-934), with interesting antibacterial and pharmacokinetic characteristics.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacteria; Chromatography, High Pressure Liquid; Dogs; Female; Fluoroquinolones; Macaca fascicularis; Male; Quinolones; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution | 1988 |
Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Fluoroquinolones; Klebsiella pneumoniae; Ofloxacin; Quinolones; Rats | 1987 |
Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo results.
Topics: Animals; Anti-Infective Agents; Candidiasis; Fluoroquinolones; Humans; Immunity, Cellular; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Macrophages; Male; Mice; Phagocytosis; Quinolones | 1994 |
In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
Topics: Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma; Quinolones; Thiazines; Ureaplasma urealyticum | 1994 |
Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter jejuni; Colistin; Digestive System; Doxycycline; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrionaceae | 1994 |
Biliary excretion of rufloxacin in humans.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Bile; Biliary Tract; Cholestasis, Extrahepatic; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones | 1993 |
The penetration of rufloxacin into sites of potential infection in the respiratory tract.
Topics: Anti-Infective Agents; Bronchi; Bronchoalveolar Lavage Fluid; Epithelium; Female; Fluoroquinolones; Humans; Lung; Macrophages, Alveolar; Male; Middle Aged; Mucous Membrane; Quinolones; Respiratory Tract Infections | 1993 |
Disk susceptibility testing for rufloxacin.
Topics: Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1993 |
In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis.
Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; CD4-CD8 Ratio; Cell Division; Ciprofloxacin; Female; Fluoroquinolones; Mice; Mice, Inbred C3H; Organ Size; Quinolones; Spleen; T-Lymphocyte Subsets; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1993 |
Quinolinecarboxylic acids. 3. Synthesis and antibacterial evaluation of 2-substituted-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de] [1,4]benzothiazine-6-carboxylic acids related to rufloxacin.
Topics: Animals; Anti-Infective Agents; Benzothiadiazines; Carboxylic Acids; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Hydrocarbons, Fluorinated; Male; Microbial Sensitivity Tests; Piperazines; Quinolines; Quinolones; Rats; Rats, Wistar; Staphylococcus aureus; Structure-Activity Relationship; Sulfones | 1993 |
Pharmacokinetics of rufloxacin in patients with impaired renal function.
Topics: Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Male; Middle Aged; Quinolones; Regression Analysis; Renal Dialysis | 1993 |
Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Quinolones | 1993 |
[Rufloxacin: the first quinolone, the fruit of Italian research].
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Quinolones; Tablets | 1993 |
Comparison of the mechanism of action and resistance of two new fluoroquinolones, rufloxacin and MF961 with those of ofloxacin and fleroxacin in gram-negative and gram-positive bacteria.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mutation; Ofloxacin; Quinolones; Rec A Recombinases | 1993 |
Breakpoint determination: rufloxacin.
Topics: Anti-Infective Agents; Bronchitis; Chronic Disease; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections | 1993 |
Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
Topics: Adult; Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Fluoroquinolones; Half-Life; Humans; Kidney; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Quinolones | 1993 |
Simultaneous determination of rufloxacin and theophylline by high-performance liquid chromatography in human plasma.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Quinolones; Theophylline | 1995 |
In vitro activity of MF 5137, a new potent 6-aminoquinolone.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Ciprofloxacin; Culture Media; Fluoroquinolones; Isoquinolines; Microbial Sensitivity Tests; Quinolones | 1995 |
Simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma using high-performance liquid chromatography.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Phenylacetates; Phenylbutyrates; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1996 |
Simultaneous determination of furprofen and rufloxacin in human plasma by high-performance liquid chromatography.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Phenylpropionates; Quinolones; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1996 |
Rufloxacin enhances susceptibility of Escherichia coli to leukocyte activity.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Quinolones | 1995 |
A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; France; Germany; Italy; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Spain; United Kingdom; Urinary Tract Infections | 1996 |
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1997 |
Design and optimization of the variables in the adsorptive stripping voltammetric determination of rufloxacin in tablets, human plasma and urine.
Topics: Absorption; Anti-Infective Agents; Calibration; Chromatography, High Pressure Liquid; Electrochemistry; Fluoroquinolones; Humans; Multivariate Analysis; Polarography; Quinolones; Regression Analysis; Tablets | 1995 |
Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors.
Topics: Anti-Infective Agents; Bacterial Adhesion; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Neutrophils; Phagocytosis; Quinolones; Respiratory Burst; Virulence | 1999 |
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Enoxacin; Enrofloxacin; Escherichia coli; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Quinolones; Spheroplasts; Staphylococcus aureus; Temperature | 1999 |
Molecular mechanisms of photosensitization induced by drugs. XII. Photochemistry and photosensitization of rufloxacin: an unusual photodegradation path for the antibacterials containing a fluoroquinolone-like chromophore.
Topics: Anti-Infective Agents; Erythrocytes; Fluoroquinolones; Hemolysis; Humans; Lipid Peroxidation; Photochemistry; Photosensitizing Agents; Quinolones; Ultraviolet Rays | 1999 |
Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges.
Topics: Adult; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Meningitis; Middle Aged; Quinolones | 2000 |
[Synthesis and antibacterial activity of tricycic fluoroquinolones].
Topics: Anti-Infective Agents; Fluoroquinolones; Quinolones | 1997 |
Optimization and validation of a CZE method for rufloxacin hydrochloride determination in coated tablets.
Topics: Anti-Infective Agents; Electrophoresis, Capillary; Fluoroquinolones; Quinolones; Reproducibility of Results; Research Design; Tablets, Enteric-Coated | 2002 |
Type II guanine oxidation photoinduced by the antibacterial fluoroquinolone Rufloxacin in isolated DNA and in 2'-deoxyguanosine.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Deoxyguanosine; DNA; Fluoroquinolones; Guanine; Kinetics; Lasers; Luminescent Measurements; Oxidation-Reduction; Oxygen; Photochemistry; Photosensitizing Agents; Quinolones; Spectrophotometry, Ultraviolet | 2002 |
Photoinduced N-demethylation of rufloxacin and its methyl ester under aerobic conditions.
Topics: Anti-Infective Agents; Fluoroquinolones; Methylation; Photochemistry; Quinolones; Spectrometry, Fluorescence | 2002 |
[Determination of rufloxacin in human plasma by high performance liquid chromatography].
Topics: Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Quinolones | 2000 |
Photochemical properties of ofloxacin involved in oxidative DNA damage: a comparison with rufloxacin.
Topics: Anti-Bacterial Agents; DNA Damage; Fluorescence; Fluoroquinolones; Hydrogen Peroxide; Lasers; Ofloxacin; Oxidation-Reduction; Photochemistry; Quinolones; Time Factors | 2003 |
A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.
Topics: Adhesives; Administration, Topical; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Colony Count, Microbial; Excipients; Eye; Fluoroquinolones; Keratitis; Mucous Membrane; Ofloxacin; Plant Extracts; Pseudomonas Infections; Quinolones; Rabbits; Seeds; Staphylococcal Infections; Tamarindus | 2004 |
Rufloxacin induced photosensitization in bio-models of increasing complexity.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Cells, Cultured; Comet Assay; Deoxyguanosine; DNA Repair; Fibroblasts; Fluoroquinolones; Photosensitizing Agents; Quinolones; Ultraviolet Rays | 2005 |
Pharmacokinetics of rufloxacin (MF-934) in normal human volunteers after single oral administration.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Metabolic Clearance Rate; Quinolones; Reference Values | 1989 |
Rufloxacin-induced photosensitization in yeast.
Topics: Cell Survival; Chromatography, High Pressure Liquid; DNA Fragmentation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluoroquinolones; Formaldehyde; Hydrogen Peroxide; Mass Spectrometry; Molecular Structure; Photosensitizing Agents; Quinolones; Saccharomyces cerevisiae; Sensitivity and Specificity; Ultraviolet Rays | 2007 |